Literature DB >> 18985403

[Health services research based on routine data generated by the SHI. Potential uses of health insurance fund data in health services research].

I Schubert1, I Köster, J Küpper-Nybelen, P Ihle.   

Abstract

Conducting health services research requires a wealth of real-life health service data. A source of data which is for the most part free of bias is the data collected for administrative purposes by the statutory health insurance fund. These data have been increasingly used over the past few years. Based on these insuree-related and where possible cross-sector data, descriptive and analytic studies can be conducted. The focus of use thus far has primarily been the generation of basic data on morbidity, the utilization of benefits, and costs. As a rule, this information is presented according to sociodemographic variables and where applicable in terms of temporal trends and according to region. A further domain of interest is the evaluation of interventions (health political measures, legislation, programs) and the assessment of health service quality. Initial outcome studies have been published. Despite the growing acceptance and use of these data, a series of methodological and information technical challenges remain to be addressed: To be mentioned are, in addition to validation studies, the methodological requirements of analytic study designs and the possibility of a data linkage with primary data in order to increase the explanatory power of studies and to facilitate links with other databases such as records and survey data.

Mesh:

Year:  2008        PMID: 18985403     DOI: 10.1007/s00103-008-0644-0

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  23 in total

1.  [Health services research in oncology using claims data].

Authors:  Falk Hoffmann; Gerd Glaeske
Journal:  Med Klin (Munich)       Date:  2010-06-26

2.  [Limits in health services research].

Authors:  C Röllig
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

3.  [Health services research in urology: basis and examples].

Authors:  G Glaeske
Journal:  Urologe A       Date:  2014-12       Impact factor: 0.639

Review 4.  [An essay on health services research-contributions from urology].

Authors:  P J Goebell
Journal:  Urologe A       Date:  2018-08       Impact factor: 0.639

5.  Differences in the Incidence of Gestational Diabetes between Women of Turkish and German Origin: An Analysis of Health Insurance Data From a Statutory Health Insurance in Berlin, Germany (AOK), 2005-2007.

Authors:  A Reeske; H Zeeb; O Razum; J Spallek
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-04       Impact factor: 2.915

6.  Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data.

Authors:  Larissa Schwarzkopf; Petra Menn; Reiner Leidl; Sonja Wunder; Hilmar Mehlig; Peter Marx; Elmar Graessel; Rolf Holle
Journal:  BMC Health Serv Res       Date:  2012-06-19       Impact factor: 2.655

7.  Gesundes Kinzigtal Integrated Care: improving population health by a shared health gain approach and a shared savings contract.

Authors:  Hildebrandt H; Hermann C; Knittel R; Richter-Reichhelm M; Siegel A; Witzenrath W
Journal:  Int J Integr Care       Date:  2010-06-23       Impact factor: 5.120

8.  Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis.

Authors:  I Müller; M H Freitag; G Poggensee; E Scharnetzky; E Straube; Ch Schoerner; H Hlobil; H-J Hagedorn; G Stanek; A Schubert-Unkmeir; D E Norris; J Gensichen; K-P Hunfeld
Journal:  Clin Dev Immunol       Date:  2011-12-27

9.  Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.

Authors:  Christoph Ohlmeier; Ingo Langner; Kathrin Hillebrand; Niklas Schmedt; Rafael Mikolajczyk; Oliver Riedel; Edeltraut Garbe
Journal:  BMC Public Health       Date:  2015-06-20       Impact factor: 3.295

10.  Cost of illness and economic burden of chronic lymphocytic leukemia.

Authors:  Carl Rudolf Blankart; Taika Koch; Roland Linder; Frank Verheyen; Jonas Schreyögg; Tom Stargardt
Journal:  Orphanet J Rare Dis       Date:  2013-02-20       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.